Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zoltan Matrai

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Hematology (Amsterdam, Netherlands)|July 16, 2005
CD38 as a prognostic marker in CLLZoltan Matrai
Leukemia & Lymphoma|June 14, 2003
Correlation between cell size and CD38 expression in chronic lymphocytic leukaemiaSameer Manocha, Zoltan Matrai, Michael Osthoff, et al.
Blood|August 1, 2002
Relationship between p53 dysfunction, CD38 expression, and IgV(H) mutation in chronic lymphocytic leukemiaKe Lin, Paul D Sherrington, Michael Dennis, et al.
Familial Cancer|October 9, 2015
Contribution of APC and MUTYH mutations to familial adenomatous polyposis susceptibility in HungaryJanos Papp, Marietta Eva Kovacs, Zoltan Matrai, et al.
Cancer Research|August 17, 2005
B-cell receptor translocation to lipid rafts and associated signaling differ between prognostically important subgroups of chronic lymphocytic leukemiaDavid J Allsup, Aura S Kamiguti, Ke Lin, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 21, 2020
Theoretical and practical knowledge curriculum for European Breast SurgeonsTibor Kovacs, Isabel T Rubio, Christos Markopoulos, et al.
Eclinicalmedicine|January 25, 2021
What we learned in axillary management of breast cancer patients at the American society of clinical oncology (ASCO) 2020 virtual meeting? The EUBREAST point of viewMaria Luisa Gasparri, Philip Poortmans, Maggie Banys-Paluchowski, et al.
Haematologica|July 28, 2011
The prognostic impact of germline 46/1 haplotype of Janus kinase 2 in cytogenetically normal acute myeloid leukemiaSarolta Nahajevszky, Hajnalka Andrikovics, Arpad Batai, et al.
The Lancet. Oncology|August 8, 2020
Knowledge gaps in oncoplastic breast surgeryWalter P Weber, Monica Morrow, Jana de Boniface, et al.
Annals of Surgical Oncology|October 31, 2023
Impact of Imaging-Guided Localization on Performance of Tailored Axillary Surgery in Patients with Clinically Node-Positive Breast Cancer: Prospective Cohort Study Within TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)Walter P Weber, Martin Heidinger, Stefanie Hayoz, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Hematology (Amsterdam, Netherlands)|July 16, 2005
CD38 as a prognostic marker in CLLZoltan Matrai
Leukemia & Lymphoma|June 14, 2003
Correlation between cell size and CD38 expression in chronic lymphocytic leukaemiaSameer Manocha, Zoltan Matrai, Michael Osthoff, et al.
Blood|August 1, 2002
Relationship between p53 dysfunction, CD38 expression, and IgV(H) mutation in chronic lymphocytic leukemiaKe Lin, Paul D Sherrington, Michael Dennis, et al.
Familial Cancer|October 9, 2015
Contribution of APC and MUTYH mutations to familial adenomatous polyposis susceptibility in HungaryJanos Papp, Marietta Eva Kovacs, Zoltan Matrai, et al.
Cancer Research|August 17, 2005
B-cell receptor translocation to lipid rafts and associated signaling differ between prognostically important subgroups of chronic lymphocytic leukemiaDavid J Allsup, Aura S Kamiguti, Ke Lin, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 21, 2020
Theoretical and practical knowledge curriculum for European Breast SurgeonsTibor Kovacs, Isabel T Rubio, Christos Markopoulos, et al.
Eclinicalmedicine|January 25, 2021
What we learned in axillary management of breast cancer patients at the American society of clinical oncology (ASCO) 2020 virtual meeting? The EUBREAST point of viewMaria Luisa Gasparri, Philip Poortmans, Maggie Banys-Paluchowski, et al.
Haematologica|July 28, 2011
The prognostic impact of germline 46/1 haplotype of Janus kinase 2 in cytogenetically normal acute myeloid leukemiaSarolta Nahajevszky, Hajnalka Andrikovics, Arpad Batai, et al.
The Lancet. Oncology|August 8, 2020
Knowledge gaps in oncoplastic breast surgeryWalter P Weber, Monica Morrow, Jana de Boniface, et al.
Annals of Surgical Oncology|October 31, 2023
Impact of Imaging-Guided Localization on Performance of Tailored Axillary Surgery in Patients with Clinically Node-Positive Breast Cancer: Prospective Cohort Study Within TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)Walter P Weber, Martin Heidinger, Stefanie Hayoz, et al.
Pageof 3